FDA temporarily shutters ‘filthy’ compounding pharmacySeveral years ago, drugs compounded by Franck’s Compounding Lab caused eye infections that lead to vision loss.
The biosimilar balance: More options, lower costsThe fly in the ointment: CMS' current plan for HCPCS codes is a real buzz kill.
FDA no longer supports use of niacin, fenofibric acid with statinsFDA has withdrawn its approval for niacin and fenofibric acid use with statins to treat high cholesterol.
FDA generics backlog improves, although criticism continuesWhile many groups are criticizing the FDA backlog of generic drug approvals, the agency has released the numbers on approvals and tentative approvals for 2015.
  • 1
  • 2